Evoke Pharma Inc·4

Mar 24, 4:30 PM ET

Kowieski Mark 4

4 · Evoke Pharma Inc · Filed Mar 24, 2025

Insider Transaction Report

Form 4
Period: 2025-03-20
Kowieski Mark
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2025-03-20$3.21/sh+4,500$14,4634,916 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4